March special issue: What to do about Taiwan

bioweapons

A US national labs researcher studying viruses.

How to tell biodefense from an offensive bioweapons program

By Dan Regan, Rhys Dubin | Biosecurity

Can a 1975 bioweapons ban handle today’s biothreats?

By Matt Field | Biosecurity

Russian ambassador to the United Nations.

Russia (again) peddles its debunked US-Ukrainian bioweapons claims at the United Nations

By Jez Littlewood, Filippa Lentzos | Biosecurity

Russia’s alleged bioweapons claims have few supporters

By Jez Littlewood, Filippa Lentzos | Biosecurity

Fear and Loathing in Moscow: The Russian biological weapons program in 2022

By Robert Petersen | Biosecurity

A monkeypox protest

The Strategic National Stockpile failed during COVID and monkeypox. Will it come through next time?

By Matt Field | Biosecurity

Russian ambassador to the United Nations.

Russia amplifies bioweapons claims at the United Nations Security Council

By Matt Field | Biosecurity

In Ukraine, US-military-linked labs could provide fodder for Russian disinformation

By Matt Field | Biosecurity

Representatives to the Biological Weapons Convention meet.

Don’t let finger-pointing doom this key treaty against bioweapons

By Filippa Lentzos, Jez Littlewood | Biosecurity

Soldier donning a gas mask.

The Biological Weapons Convention protocol should be revisited

By Lynn Klotz | Biosecurity, Opinion

Why cooperative threat reduction still matters—Especially for biological dangers

By Amy E. Smithson | Biosecurity, Disruptive Technologies, Uncategorized

Biosecurity: The opportunities and threats of industrialization and personalization

By Gigi Kwik Gronvall | Biosecurity